Constellium (NYSE:CSTM) Director John Ormerod Sells 8,000 Shares

Constellium SE (NYSE:CSTM) Director John Ormerod sold 8,000 shares of the business’s stock in a transaction that occurred on Thursday, June 4th. The shares were sold at an average price of $35.01, for a total value of $280,080.00. Following the completion of the sale, the director directly owned 24,873 shares of the company’s stock, valued at approximately $870,803.73. The trade was a 24.34% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link.

Constellium Trading Up 0.9%

Shares of NYSE CSTM opened at $34.20 on Tuesday. The stock has a market cap of $4.66 billion, a price-to-earnings ratio of 11.07 and a beta of 1.55. The business has a 50 day simple moving average of $31.37 and a 200 day simple moving average of $25.08. Constellium SE has a 52 week low of $12.68 and a 52 week high of $36.99. The company has a debt-to-equity ratio of 1.71, a quick ratio of 0.60 and a current ratio of 1.39.

Constellium (NYSE:CSTM) last announced its quarterly earnings results on Wednesday, April 29th. The industrial products company reported $1.42 EPS for the quarter, beating the consensus estimate of $0.62 by $0.80. The business had revenue of $2.46 billion during the quarter, compared to analysts’ expectations of $2.43 billion. Constellium had a return on equity of 46.22% and a net margin of 4.87%.The firm’s quarterly revenue was up 24.4% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.26 EPS. On average, research analysts predict that Constellium SE will post 3.34 earnings per share for the current fiscal year.

Constellium declared that its board has authorized a share repurchase plan on Thursday, March 12th that allows the company to buyback $300.00 million in outstanding shares. This buyback authorization allows the industrial products company to reacquire up to 8.8% of its stock through open market purchases. Stock buyback plans are often a sign that the company’s management believes its shares are undervalued.

Institutional Investors Weigh In On Constellium

Several hedge funds have recently modified their holdings of CSTM. Arrowstreet Capital Limited Partnership boosted its position in shares of Constellium by 620.9% in the first quarter. Arrowstreet Capital Limited Partnership now owns 3,228,027 shares of the industrial products company’s stock valued at $79,345,000 after acquiring an additional 2,780,260 shares during the period. Healthcare of Ontario Pension Plan Trust Fund boosted its position in shares of Constellium by 894.4% in the first quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 2,056,336 shares of the industrial products company’s stock valued at $50,545,000 after acquiring an additional 1,849,554 shares during the period. Millennium Management LLC boosted its position in shares of Constellium by 35.4% in the third quarter. Millennium Management LLC now owns 6,935,766 shares of the industrial products company’s stock valued at $103,204,000 after acquiring an additional 1,813,400 shares during the period. Morgan Stanley boosted its position in shares of Constellium by 48.4% in the fourth quarter. Morgan Stanley now owns 3,728,118 shares of the industrial products company’s stock valued at $70,275,000 after acquiring an additional 1,216,516 shares during the period. Finally, Scopus Asset Management L.P. bought a new stake in shares of Constellium in the second quarter valued at approximately $14,054,000. 92.59% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of research firms have recently weighed in on CSTM. Zacks Research upgraded shares of Constellium from a “hold” rating to a “strong-buy” rating in a report on Tuesday, May 12th. UBS Group began coverage on shares of Constellium in a report on Tuesday, May 5th. They set a “buy” rating and a $38.00 price target on the stock. JPMorgan Chase & Co. reaffirmed a “neutral” rating and set a $34.00 target price (up from $30.00) on shares of Constellium in a research report on Thursday, April 30th. BMO Capital Markets set a $32.00 target price on Constellium and gave the stock an “outperform” rating in a research report on Thursday, April 9th. Finally, Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Constellium in a research report on Tuesday, May 26th. Two analysts have rated the stock with a Strong Buy rating, three have issued a Buy rating and two have given a Hold rating to the company. According to data from MarketBeat.com, the company has an average rating of “Buy” and a consensus target price of $36.60.

Constellium Company Profile

Constellium SE is a global leader in the design and manufacture of high-performance aluminum products and solutions. The company serves key markets including aerospace, automotive, and packaging, offering advanced rolled and extruded aluminum sheet, plate and structural components. Its product portfolio encompasses precision-engineered parts for commercial and military aircraft, automotive body structures and closures, beverage and specialty packaging, as well as industrial and structural applications.

Established in 2011 through the consolidation of Rio Tinto Alcan’s rolled-products and engineered-products businesses, Constellium has built a reputation for innovation in lightweighting and sustainability.